1.Prevalence of hepatitis viral markers in patients with hepatocellular carcinoma and extrahepatic neoplasm
Journal of Medical Research 2005;37(4):33-37
Objectives: studying the seroprevalence of HBsAg and anti-HCV in patients with hepatocellular carcinoma (HCC) and neoplasm of non-liver organs. Subjects and method: 124 patients with HCC and 284 patients with neoplasm of non-liver organs (i.e. stomach, colorectus and lung) were treated at Bach Mai Hospital and Viet Duc Hospital. This cross-sectional study was conductedfrom January 2002 to April 2003. Results: Out of 124 patients with HCC, HBsAg positive found in 95/124 (76.6%), anti- HCV positive found in 2/61 (3.28%), both HBsAg and anti-HCV posititive found in 1/61 (1.64%), and prevalence of anti-HCV is much lower than that of HBsAg, p<0.0001. Out of 284 patient with non-liver cancer, HBsAg posititive found in 33/284 (11.62%), and none among 179 patients has anti-HCV posititive. The prevalence of HBsAg posititive in HCC group is much higher than in non-liver cancer group (p<0.0001, OR=24.92).
Carcinoma, Hepatocellular, Neoplasms
2.Inferior vena cava and intra-cardiac invasion of hepatocellular carcinoma: a rare but catastrophic complication
Cynthia Assimta Peter ; Anand Swaroop Uppaluri ; Bak Siew Steven Wong
The Medical Journal of Malaysia 2017;72(1):58-59
Intra-cardiac extension of hepatocellular carcinoma (HCC) is
an uncommon but serious condition related to poor
prognosis. We report a 57-year-old male diagnosed with
HCC with intra-cardiac extension into the right atrium at
presentation. There were no symptoms related to cardiac
involvement and intra-cardiac extension was incidentally
noted on radiological imaging. He was offered palliative
treatment and succumbed to his disease within 50 days of
first diagnosis.
Carcinoma, Hepatocellular
;
Liver Neoplasms
6.The role of serum alpha feto-protein in the diagnosis and management of hepatocellular carcinoma
Journal of Practical Medicine 2003;458(8):42-45
Review and update some knowledge of alpha feto-protein (AFP) value in the diagnosis, prognosis and management of patients with hepatocellular carcinoma (HCC), and the role of AFP in monitoring of response to medical and surgical treatments. Serum AFP tests give sensitivity of 50% and specificity >90% at cut-off value of 500 ng/ml in the diagnosis of HCC in patients who had underlined hepatic diseases
Carcinoma, Hepatocellular
;
Liver
;
Liver Neoplasms
7.Sarcomatous hepatocellular carcinoma: Two case reports and a review of Korean clinical literature.
Chang Min LEE ; Tae Hyo KIM ; Hyun Ju MIN ; Hyun Jin KIM ; Woon Tae JUNG ; Ok Jae LEE ; Gyung Hyuck KO
Korean Journal of Medicine 2009;77(Suppl 1):S41-S47
Sarcomatous hepatocellular carcinoma (HCC) is a rare primary liver cancer. Pathogenesis of sarcomatous transformation of HCC has not yet been elucidated. Sarcomatous HCC has highly invasive and metastatic potential, compared with ordinary HCC. We present here two cases of sarcomatous hepatocellular carcinoma with an unfavorable prognosis. Other cases reported in Korean literature of this uncommon tumor were also reviewed.
Carcinoma, Hepatocellular
;
Liver Neoplasms
;
Prognosis
Result Analysis
Print
Save
E-mail